RxDoctor Payments Data

Amanda Corcoran, CNM

Advanced Practice Midwife · New Haven, CTNPI 1346607785

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $1,045 of the $1,350 with a category attached, or 77.4%. Organon accounts for 78.9% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $1,066 and has fallen 87.7% since, to $131 in 2025. Among advanced practice midwife clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,350in general payments, 2019–2025

Across 15 payments — averaging $90.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organon$1K
  • AbbVie$65
  • Exeltis, USA Inc.$44
  • Pfizer$29
  • Millicent US Inc$25
  • Aspira Women's Health Inc$24
  • plus $97 from 5 others

What the payments were for

  • Speaking & faculty fees$1,04577%
  • Food & beverage$30523%

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,350 in reported general payments places this provider in the 95th percentile of 129 advanced practice midwife providers in Connecticut.

See all advanced practice midwife providers in Connecticut

Medicare billing

Part B allowed, 2024
$6,759
Medicare patients
44
Services billed
138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol26$2,525
ValacyclovirValacyclovir Hcl23$590
Terconazole11$335
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst16$121

Paid to pharmacies, not to this prescriber.

Other advanced practice midwife in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →